medigraphic.com
Colegio de Medicina Interna de México.

2022, Number 2

<< Back Next >>

Med Int Mex 2022; 38 (2)

Bacterial meningitis in adults. Clinical approach of literature

Cerda-Mancillas MC, Martínez-Marino M, Pérez-Pérez JR, Flores-Silva FD, Valle-Murillo MÁ, Sánchez-Jordán A

Language: Spanish
References: 32
Page: 335-343
PDF size: 380.22 Kb.


ABSTRACT

Bacterial meningitis is a neurological emergency because the delay in treatment increases morbidity and mortality significantly. The immediate approach and empirical treatment depend on multiple variables that clinicians must answer at the emergency room with the purpose of covering the microorganisms in which there is high suspicion. Diagnostic tests are tools of high performance for diagnosis and follow up; however, there are precise indications to be performed immediately. The aim of this document is to comprehensively review the approach and treatment of the clinician against bacterial meningitis.


REFERENCES

  1. Lieb SL, Tauber M. Acute and chronic meningitis. In: Cohen J, Powderly W, editors. Infectious diseases. 2nd edition. Mosby; 2004, 251-65.

  2. OMS (Organización Mundial de la Salud). Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine. Wkly Epidemiol Rep 2010; 85 (43): 425-36.

  3. Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, et al. Bacterial Meningitis in the United States, 1998-2007. N Engl J Med 2011; 364 (21): 2016-25. doi: 10.1056/NEJMoa1005384.

  4. Solórzano SF, Miranda NMG, Díaz RRD. Meningoencefalitis bacteriana. Enf Infecc Microbiol 2002; 22 (1): 2-13.

  5. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS, et al. Acute bacterial meningitis in adults -- a review of 493 episodes. N Engl J Med 1993; 328 (1): 21-8. DOI: 10.1056/NEJM199301073280104.

  6. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998; 129 (11): 862-9. doi: 10.7326/0003-4819-129- 11_part_1-199812010-00004.

  7. Tang LM, Chen ST, Hsu WC, Lyu RK. Acute bacterial meningitis in adults: a hospital-based epidemiological study. QJM 1999; 92 (12): 719-25. doi: 10.1093/qjmed/92.12.719.

  8. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351 (18): 1849-59. doi: 10.1056/NEJMoa040845.

  9. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997; 337 (14): 970-6. DOI: 10.1056/ NEJM199710023371404.

  10. Hussein AS, Shafran SD. Acute bacterial meningitis in adults. A 12-year review. Medicine (Baltimore) 2000; 79 (6): 360-8. doi: 10.1097/00005792-200011000-00002.

  11. Tunkel A. Epidemiology of bacterial meningitis in adults. UptoDate 2016.

  12. McClelland S, Hall WA. Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis 2007; 45 (1): 55-9. doi: 10.1086/518580.

  13. van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med 2010; 362 (2): 146-54. doi: 10.1056/NEJMra0804573.

  14. Tebruegge M, Curtis N. Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis. Clin Microbiol Rev 2008; 21 (3): 519-37. doi: 10.1128/CMR.00009-08.

  15. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI. Tissuespecific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 2004; 190 (9): 1661-9. doi: 10.1086/424596.

  16. Unkmeir A, Latsch K, Dietrich G, Wintermeyer E, Schinke B, Schwender S, et al. Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells. Mol Microbiol 2002; 46 (4): 933-46. doi: 10.1046/j.1365-2958.2002.03222.x.

  17. Källström H, Liszewski MK, Atkinson JP, Jonsson AB. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol 1997; 25 (4): 639-47. doi: 10.1046/j.1365-2958.1997.4841857.x.

  18. Koedel U, Klein M, Pfister H-W. New understandings on the pathophysiology of bacterial meningitis. Curr Opin Infect Dis 2010; 23 (3): 217-23. doi: 10.1097/ QCO.0b013e328337f49e.

  19. Attia J, Hatala R, Cook D, Wong J. Does this adult patient have acute meningitis? In: Simel D, Rennie D, editors. The Rational Clinical Examination: Evidence-Based Clinical Diagnosis. New York: McGrawHill; 2009.

  20. Thomas KE, Hasbun R, Jekel J, Quagliarello VJ. The diagnostic accuracy of Kernig’s sign, Brudzinski’s sign, and nuchal rigidity in adults with suspected meningitis. Clin Infect Dis 2002; 35 (1): 46-52.

  21. Uchihara T, Tsukagoshi H. Jolt accentuation of headache: the most sensitive sign of CSF pleocytosis. Headache 1991; 31 (3): 167-71. doi: 10.1111/j.1526-4610.1991.hed3103167.x.

  22. Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001; 345 (24): 1727-33. DOI: 10.1056/NEJMoa010399.

  23. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004; 39 (9): 1267- 84. https://doi.org/10.1086/425368.

  24. Poppert S, Essig A, Stoehr B, Steingruber A, Wirths B, Juretschko S, et al. Rapid diagnosis of bacterial meningitis by real-time pcr and fluorescence in situ hybridization. J Clin Microbiol 2005; 43 (7): 3390-7. doi: 10.1128/ JCM.43.7.3390-3397.2005.

  25. Cabrera-Gaytán DA, Pérez-Pérez GF, Arriaga-Nieto L, Vallejos-Parás A, Padilla-Velázquez R, Grajales-Muñiz C. Epidemiological surveillance of meningeal and encephalic syndrome in the Mexican Social Security Instituto, 2012- 2014. Rev Med Hosp Gen Méx 2017; 80 (3): 130-138. DOI: 10.1016/j.hgmx.2016.06.014.

  26. Karageorgopoulos DE, Valkimadi PE, Kapaskelis A, Rafailidis PI, Falagas ME. Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children. Arch Dis Child 2009; 94 (8): 607-14. doi: 10.1136/adc.2008.151563.

  27. McGill F, Heyderman RS, Michael BD, Defres S, Beeching NJ, Borrow R, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect 2016; 72 (4): 405-38. doi: 10.1016/j. jinf.2016.01.007.

  28. Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2015; (9): CD004405. doi: 10.1002/14651858. CD004405.pub5.

  29. Borchorst S, Møller K. The role of dexamethasone in the treatment of bacterial meningitis - a systematic review. Acta Anaesthesiol Scand 2012; 56 (10): 1210-21. doi: 10.2147/PPA.S109720.

  30. van de Beek D, Farrar JJ, de Gans J, Mai NTH, Molyneux EM, Peltola H, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010; 9 (3): 254-63. doi: 10.1016/S1474- 4422(10)70023-5.

  31. Jit M. The risk of sequelae due to pneumococcal meningitis in high-income countries: A systematic review and meta-analysis. J Infect 2010; 61 (2): 114-24. doi: 10.1016/j. jinf.2010.04.008.

  32. Chaudhuri A, Martin PM, Kennedy PGE, Andrew Seaton R, Portegies P, Bojar M, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008; 15 (7): 649-59. doi: 10.1111/j.1468-1331.2008.02193.x.




2020     |     www.medigraphic.com